Developer docs
API playgroundTry for free, no card

Search company profiles

Arterys

Full company profile

uuid00037ox

Namestring
Arterys
Legal namestring
Arterys
Websiteurl
arterys.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments, with particular focus on cardiology and oncology imaging studies. Founded in 2013 and headquartered in San Francisco, the platform operates as a validated medical device accessible from any validated device via the cloud, with no PHI exchange required, and integrates directly into existing PACS or EHR-driven clinical workflows so that AI capabilities are a natural extension of how radiologists already work. Underlying the platform are deep learning computer vision models applied across modalities including CT, MRI, and mammography, used to flag urgent findings, manage rising imaging volumes, and improve diagnostic accuracy amid radiologist shortages.

The product processes DICOM and other medical imaging formats and combines image analysis with multimodal clinical data integration, enabling actionable diagnostic insights rather than isolated stand-alone reads. Prior to its acquisition by Tempus AI in 2022, Arterys had raised approximately $71.7 million across eight funding events with strategic participation from Temasek, GE Ventures, Varian, Northwell Ventures, NewYork-Presbyterian Ventures, and Fosun Capital, validating institutional and ecosystem confidence in the platform. Following the acquisition, the product has been reintroduced as Tempus Radiology and is being integrated into Tempus's broader precision medicine stack, extending the offering from clinical diagnostic use into life sciences research and drug development by leveraging radiology as a new data modality alongside Tempus's molecular and clinical assets.

Arterys generates revenue through an enterprise SaaS subscription model, with quote-based (non-public) pricing sold via direct enterprise sales to hospitals, health systems, and radiology departments. The go-to-market motion is field-led and integration-heavy: deals involve technical integration with PACS/EHR systems, validation against clinical workflows, and ongoing customer success. Distribution is now channeled through Tempus's existing healthcare provider and pharmaceutical relationships, materially broadening reach relative to Arterys's pre-acquisition direct footprint. Direct marketing emphasizes clinical publications, industry conference presence, FDA-related regulatory positioning, and PACS/EHR integration partnerships rather than consumer or SMB channels, consistent with the enterprise radiology AI category.

Short descriptiontext

Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments in hospitals and health systems. Founded in 2013, acquired by Tempus AI in 2022, and now operating as Tempus Radiology, it focuses primarily on cardiology and oncology imaging workflows.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical imaging AI, cloud radiology platform, radiology workflow automation, PACS EHR integration, AI diagnostic imaging
Industry4 codes
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI / Radiology AI Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Imaging AI SaaS Platform
TypeSubscription Recurring
Description

Arterys generates revenue through a cloud-based SaaS subscription model for its medical imaging AI platform. Healthcare institutions pay for access to AI-powered diagnostic tools that integrate directly into their clinical workflows. The platform extracts actionable insights from medical images to improve diagnostic decision-making, efficiency, and productivity, serving as a validated medical device in radiology departments.

arterys.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Arterys provides a cloud-based medical imaging AI platform that extracts actionable insights from radiology images (CT, MRI, mammography) to improve diagnostic decision-making, efficiency, and productivity. The platform weaves leading AI clinical applications directly into existing PACS or EHR-driven workflows across cardiology and oncology use cases, operating as a validated medical device with no PHI exchange required. Following its 2022 acquisition by Tempus AI, the product is being integrated into Tempus' broader precision medicine platform and reintroduced as Tempus Radiology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Arterys is referenced as a leading AI radiology tool alongside Aidoc and Gleamer for triage and flagging functionality
Product overview1 text field

Arterys is a cloud-based medical imaging AI platform that functions as the radiology AI component within the broader Tempus precision medicine ecosystem. Following Tempus's 2022 acquisition of Arterys, the platform has been rebranded as Tempus Radiology, integrating AI-powered image analysis into Tempus's existing data and AI infrastructure. The platform operates exclusively via the cloud, requiring no PHI exchange, and provides visualization, quantification, and triage capabilities across multiple radiology modalities (CT, MRI, mammography, and others) for cardiology and oncology use cases. The Arterys product serves as the core medical imaging AI engine that enables providers to access a comprehensive patient view inclusive of radiology scans, and researchers to leverage this new imaging data modality to optimize drug development.

Product and service1 record
1Arterys Medical Imaging AI Platform
CategoryMedical Imaging AI / Radiology AI Software
Description

A cloud-based medical imaging AI platform that extracts actionable insights from radiology images to improve diagnostic decision-making, efficiency, and patient outcomes by weaving AI clinical applications into existing PACS or EHR-driven workflows for hospitals, health systems, and radiology departments across cardiology and oncology use cases.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

RapidAI delivers AI imaging solutions for stroke, aneurysm, and other vascular conditions, integrated into hospital PACS workflows. It is directly comparable to Arterys in product category, hospital-system sales motion, and AI-augmented radiology decision-making.

2Tempus AI
TypeBroad incumbent
Description

Tempus AI is the parent company of Arterys (now Tempus Radiology), operating a broader precision medicine platform spanning genomics, clinical data, and now imaging. It is a broad incumbent whose strategy now sets Arterys's trajectory and provides distribution scale.

TypeDirect peer
Description

Viz.ai provides AI-powered medical imaging analysis focused on stroke and acute care triage, integrated with hospital workflows. It is directly comparable to Arterys in target customers (hospital systems), enterprise SaaS model, and AI-driven radiology decision support.

TypeDirect peer
Description

Qure.ai builds deep learning models for medical imaging interpretation across chest, head, and musculoskeletal use cases, deployed in hospitals globally. It is directly comparable to Arterys in AI radiology technology and enterprise hospital sales approach.

5Nanox (formerly Zebra Medical Vision)
TypeDirect peer
Description

Zebra Medical Vision, now part of Nanox, developed AI algorithms for radiology image analysis deployed across multiple modalities. It is directly comparable to Arterys as an AI medical imaging platform serving hospital radiology departments.

TypeDirect peer
Description

Aidoc is a leading medical imaging AI platform focused on radiology triage and detection, deployed across hospital systems. It is directly comparable to Arterys as both target hospital radiology workflows with AI-driven image analysis, and is cited alongside Arterys and Gleamer in industry comparisons.

TypeBroad incumbent
Description

Philips offers a broad imaging and informatics portfolio including IntelliSpace AI, an enterprise imaging AI platform. It is a broad incumbent comparable to Arterys in hospital imaging AI and enterprise radiology workflow integration.

TypeDirect peer
Description

Gleamer develops AI radiology software for triage and detection, with strong positioning in musculoskeletal and chest imaging. It is directly comparable to Arterys, referenced alongside it as a peer in the AI radiology market and competing for similar hospital contracts.

TypeBroad incumbent
Description

GE HealthCare is a major imaging equipment and informatics vendor with AI capabilities embedded across its imaging portfolio. It is a broad incumbent overlapping with Arterys in hospital radiology AI and imaging informatics, and was also an Arterys investor via GE Ventures.

TypeEmerging player
Description

Annalise.ai offers comprehensive AI radiology decision-support across a broad range of imaging findings. It is an emerging peer with meaningful overlap to Arterys in AI-powered radiology interpretation for hospital customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arterys

Medical Imaging AI / Radiology AI Softwarearterys.com

Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments in hospitals and health systems. Founded in 2013, acquired by Tempus AI in 2022, and now operating as Tempus Radiology, it focuses primarily on cardiology and oncology imaging workflows.

What Arterys does

Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments, with particular focus on cardiology and oncology imaging studies. Founded in 2013 and headquartered in San Francisco, the platform operates as a validated medical device accessible from any validated device via the cloud, with no PHI exchange required, and integrates directly into existing PACS or EHR-driven clinical workflows so that AI capabilities are a natural extension of how radiologists already work. Underlying the platform are deep learning computer vision models applied across modalities including CT, MRI, and mammography, used to flag urgent findings, manage rising imaging volumes, and improve diagnostic accuracy amid radiologist shortages.

The product processes DICOM and other medical imaging formats and combines image analysis with multimodal clinical data integration, enabling actionable diagnostic insights rather than isolated stand-alone reads. Prior to its acquisition by Tempus AI in 2022, Arterys had raised approximately $71.7 million across eight funding events with strategic participation from Temasek, GE Ventures, Varian, Northwell Ventures, NewYork-Presbyterian Ventures, and Fosun Capital, validating institutional and ecosystem confidence in the platform. Following the acquisition, the product has been reintroduced as Tempus Radiology and is being integrated into Tempus's broader precision medicine stack, extending the offering from clinical diagnostic use into life sciences research and drug development by leveraging radiology as a new data modality alongside Tempus's molecular and clinical assets.

Arterys generates revenue through an enterprise SaaS subscription model, with quote-based (non-public) pricing sold via direct enterprise sales to hospitals, health systems, and radiology departments. The go-to-market motion is field-led and integration-heavy: deals involve technical integration with PACS/EHR systems, validation against clinical workflows, and ongoing customer success. Distribution is now channeled through Tempus's existing healthcare provider and pharmaceutical relationships, materially broadening reach relative to Arterys's pre-acquisition direct footprint. Direct marketing emphasizes clinical publications, industry conference presence, FDA-related regulatory positioning, and PACS/EHR integration partnerships rather than consumer or SMB channels, consistent with the enterprise radiology AI category.

Arterys firmographics

Firmographics
Name
Arterys
Legal name
Arterys
Website
https://arterys.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
11–50 employees
Short description
Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments in hospitals and health systems. Founded in 2013, acquired by Tempus AI in 2022, and now operating as Tempus Radiology, it focuses primarily on cardiology and oncology imaging workflows.
Ownership category
akta.pro rank

Arterys industry classification

Industry
Product category
Medical Imaging AI / Radiology AI Software
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAD
Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHABAI
Imaging Informatics & Workflow (PACS/RIS/VNA)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Medical imaging AI
  • Cloud radiology platform
  • Radiology workflow automation
  • PACS EHR integration
  • AI diagnostic imaging

Where Arterys is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Arterys business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Imaging AI SaaS Platform: Arterys generates revenue through a cloud-based SaaS subscription model for its medical imaging AI platform. Healthcare institutions pay for access to AI-powered diagnostic tools that integrate directly into their clinical workflows. The platform extracts actionable insights from medical images to improve diagnostic decision-making, efficiency, and productivity, serving as a validated medical device in radiology departments.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Arterys product offering

Product offering

Core offering

Arterys provides a cloud-based medical imaging AI platform that extracts actionable insights from radiology images (CT, MRI, mammography) to improve diagnostic decision-making, efficiency, and productivity. The platform weaves leading AI clinical applications directly into existing PACS or EHR-driven workflows across cardiology and oncology use cases, operating as a validated medical device with no PHI exchange required. Following its 2022 acquisition by Tempus AI, the product is being integrated into Tempus' broader precision medicine platform and reintroduced as Tempus Radiology.

Product overview

Arterys is a cloud-based medical imaging AI platform that functions as the radiology AI component within the broader Tempus precision medicine ecosystem. Following Tempus's 2022 acquisition of Arterys, the platform has been rebranded as Tempus Radiology, integrating AI-powered image analysis into Tempus's existing data and AI infrastructure. The platform operates exclusively via the cloud, requiring no PHI exchange, and provides visualization, quantification, and triage capabilities across multiple radiology modalities (CT, MRI, mammography, and others) for cardiology and oncology use cases. The Arterys product serves as the core medical imaging AI engine that enables providers to access a comprehensive patient view inclusive of radiology scans, and researchers to leverage this new imaging data modality to optimize drug development.

Differentiator

Problem solved

Functional benefit

Products and services

  • Arterys Medical Imaging AI Platform A cloud-based medical imaging AI platform that extracts actionable insights from radiology images to improve diagnostic decision-making, efficiency, and patient outcomes by weaving AI clinical applications into existing PACS or EHR-driven workflows for hospitals, health systems, and radiology departments across cardiology and oncology use cases.

Quantifiable outcome

  • Arterys is referenced as a leading AI radiology tool alongside Aidoc and Gleamer for triage and flagging functionality

Companies that use Arterys

Customer profile

Segments2 records

Ideal customer profiles2 records

Arterys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Arterys partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Arterys competitors and assessment

Company assessment

Direct peers

  • RapidAI: RapidAI delivers AI imaging solutions for stroke, aneurysm, and other vascular conditions, integrated into hospital PACS workflows. It is directly comparable to Arterys in product category, hospital-system sales motion, and AI-augmented radiology decision-making.
  • Viz.ai: Viz.ai provides AI-powered medical imaging analysis focused on stroke and acute care triage, integrated with hospital workflows. It is directly comparable to Arterys in target customers (hospital systems), enterprise SaaS model, and AI-driven radiology decision support.
  • Qure.ai: Qure.ai builds deep learning models for medical imaging interpretation across chest, head, and musculoskeletal use cases, deployed in hospitals globally. It is directly comparable to Arterys in AI radiology technology and enterprise hospital sales approach.
  • Nanox (formerly Zebra Medical Vision): Zebra Medical Vision, now part of Nanox, developed AI algorithms for radiology image analysis deployed across multiple modalities. It is directly comparable to Arterys as an AI medical imaging platform serving hospital radiology departments.
  • Aidoc: Aidoc is a leading medical imaging AI platform focused on radiology triage and detection, deployed across hospital systems. It is directly comparable to Arterys as both target hospital radiology workflows with AI-driven image analysis, and is cited alongside Arterys and Gleamer in industry comparisons.
  • Gleamer: Gleamer develops AI radiology software for triage and detection, with strong positioning in musculoskeletal and chest imaging. It is directly comparable to Arterys, referenced alongside it as a peer in the AI radiology market and competing for similar hospital contracts.

Broad incumbents

  • Tempus AI: Tempus AI is the parent company of Arterys (now Tempus Radiology), operating a broader precision medicine platform spanning genomics, clinical data, and now imaging. It is a broad incumbent whose strategy now sets Arterys's trajectory and provides distribution scale.
  • Philips (IntelliSpace AI): Philips offers a broad imaging and informatics portfolio including IntelliSpace AI, an enterprise imaging AI platform. It is a broad incumbent comparable to Arterys in hospital imaging AI and enterprise radiology workflow integration.
  • GE HealthCare: GE HealthCare is a major imaging equipment and informatics vendor with AI capabilities embedded across its imaging portfolio. It is a broad incumbent overlapping with Arterys in hospital radiology AI and imaging informatics, and was also an Arterys investor via GE Ventures.

Emerging players

  • Annalise.ai: Annalise.ai offers comprehensive AI radiology decision-support across a broad range of imaging findings. It is an emerging peer with meaningful overlap to Arterys in AI-powered radiology interpretation for hospital customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Arterys social profiles

Digital presence

Arterys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arterys leadership team

Management profile

Number of profiles

Profiles5 records

Arterys funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arterys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arterys

What does Arterys do?

Arterys provides a cloud-based medical imaging AI platform that extracts actionable insights from radiology images (CT, MRI, mammography) to improve diagnostic decision-making, efficiency, and productivity. The platform weaves leading AI clinical applications directly into existing PACS or EHR-driven workflows across cardiology and oncology use cases, operating as a validated medical device with no PHI exchange required. Following its 2022 acquisition by Tempus AI, the product is being integrated into Tempus' broader precision medicine platform and reintroduced as Tempus Radiology.

Is Arterys a public or private company?

Arterys is a private company. It is classified as corporate owned and is currently acquired.

When was Arterys founded?

Arterys was founded in 2014. It employs 11 to 50 people.

Where is Arterys based?

Arterys is headquartered in San Francisco, United States, in the North America region.

How does Arterys make money?

One revenue line is on record: medical Imaging AI SaaS Platform.

Who are Arterys's main competitors?

Direct peers on record are RapidAI, Viz.ai, Qure.ai, Nanox (formerly Zebra Medical Vision), Aidoc and Gleamer. Broad incumbents are Tempus AI, Philips (IntelliSpace AI) and GE HealthCare. Annalise.ai is listed as an emerging player.

Does Arterys have an API?

No public API is recorded for Arterys.

What industry is Arterys in?

Arterys's product category is Medical Imaging AI / Radiology AI Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 33451 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mpo-magTempus, Median Technologies Collaborate on AI-Powered Lung Cancer ScreeningTempus AI is integrating Median Technologies' eyonis LCS AI lung cancer screening tool into its Tempus Pixel platform. The FDA-cleared software enables nodule characterization and risk stratification. An American Cancer Society study estimates 20% of eligible U.S. individuals were screened in 2024, with full participation potentially preventing 62,110 deaths over five years.Tech TimesHow Top Medical AI Tools for Radiology Imaging with Aidoc Arterys and Gleamer Triage and FlagsThis article is an educational feature examining how AI radiology tools from Aidoc, Arterys, and Gleamer are being integrated into healthcare workflows to help clinicians triage imaging studies, flag urgent findings, and manage increasing scan volumes. Each platform targets different aspects of radiology: Aidoc focuses on acute triage and emergency detection across CT scans, Arterys provides cloud-based visualization and quantification for cardiology and oncology, and Gleamer specializes in X-ray analysis for trauma and musculoskeletal imaging. The piece describes these tools as complementary solutions that integrate with existing PACS systems to reduce radiologist workload and improve detection accuracy, rather than replacing human expertise.openPR.comMedical Image Annotation Platform Market Growth in Future Scope 2026-2033 | Zebra Medical Vision • Aidoc • Arterys • Qure.aiA report on the Medical Image Annotation Platform Market forecasts significant growth from 2026 to 2033, highlighting key players such as Zebra Medical Vision, Aidoc, Arterys, and Qure.ai. The report analyzes market trends, regional differences, and technological advancements to inform strategic decisions.openPR.comAI in Healthcare Market to Reach US$ 305.96 Billion by 2033 at 30.1% CAGR, Driven by Advancements in Medical Imaging, Drug Discovery, and Precision Medicine | DataM IntelligenceAccording to DataM Intelligence, the global AI in Healthcare market reached US$27.64 billion in 2024 and is projected to grow to US$305.96 billion by 2033, representing a compound annual growth rate of 30.1% during the 2025–2033 forecast period, driven by advancements in medical imaging, drug discovery, and precision medicine. Key market developments include NVIDIA's acquisition of an AI diagnostics startup (January 2026), GE Healthcare's acquisition of a radiology AI firm (December 2025), and Microsoft's licensing agreement with a healthcare NLP innovator (November 2025), alongside product launches by Intel, Siemens Healthcare, Philips, Medtronic, Arterys, IBM, and Google. North America holds the largest market share while Asia-Pacific emerges as the fastest-growing region.YahooTEM Strengthens Radiology Portfolio With Pixel's FDA ClearanceTempus AI received 510(k) clearance from the FDA for an update to its Tempus Pixel, an AI-powered cardiac imaging platform that enhances cardiac MR image analysis capabilities. This regulatory approval allows the system to generate T1 and T2 inline maps, improving efficiency and accuracy in detecting cardiac conditions such as fibrosis and inflammation. The company previously strengthened its radiology portfolio through the 2022 acquisition of Arterys.openPR.comAI in Radiology Market 18.25% CAGR Outlook Led by Aidoc Medical Ltd AliveCor Arterys Behold Butterfly Network Caption Health Day Zero Diagnostics DiA Imaging Analysis LtdThe AI in radiology market is projected to grow at an 18.25% CAGR from 2025 to 2032, reaching a valuation of about $5 billion. Growth is driven by AI algorithms improving diagnostic accuracy and workflow efficiency, with key players including Aidoc, AliveCor, and GE Healthcare.openPR.comSoftware as a Medical Devices Market is Boosted by AI Regulatory Support and Remote Monitoring Demand|Key Players: Arterys Inc., VitalConnect., Apple, Inc., iSchemaView, inc.The software as a medical devices market reached USD 1.85 billion in 2024 and is projected to reach USD 6.11 billion by 2033, a CAGR of 69.31%. Growth is driven by AI regulatory support and remote monitoring demand, with key players including Arterys, Apple, and Siemens Healthineers.AIMultiple: High Tech Use Cases & Tools to Grow Your BusinessTop companies in AI-powered medical imagingMany medical malpractice claims against radiologists stem from diagnostic errors, which AI can help mitigate by analyzing medical images. Companies like Butterfly Network and Arterys have developed AI-powered imaging solutions that improve diagnostic accuracy and efficiency, with Butterfly's handheld ultrasound device recently receiving FDA clearance. The integration of AI in medical imaging is likely to enhance diagnostic capabilities across the healthcare sector.WhitesmithAI in Healthcare: revolutionising diagnosis speed and accuracyAI technologies are increasingly being integrated into healthcare to enhance diagnostic speed and accuracy, with systems like Stanford University's CheXNet for pneumonia detection and Arterys' Cardio AI reducing cardiac MRI analysis from an hour to 15 seconds. These tools enable diagnoses within 24 hours instead of months, improve cancer detection accuracy, and provide specialist-level insights in underserved regions. The article argues that AI will serve as a complementary tool for doctors, focusing its greatest impact on national health services and communities facing acute specialist shortages.